11-35139343-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_000610.4(CD44):​c.40C>T​(p.Leu14Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000709 in 1,409,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

CD44
NM_000610.4 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.940

Publications

0 publications found
Variant links:
Genes affected
CD44 (HGNC:1681): (CD44 molecule (IN blood group)) The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]
CD44-DT (HGNC:56175): (CD44 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27287883).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD44NM_000610.4 linkc.40C>T p.Leu14Phe missense_variant Exon 1 of 18 ENST00000428726.8 NP_000601.3 P16070-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD44ENST00000428726.8 linkc.40C>T p.Leu14Phe missense_variant Exon 1 of 18 1 NM_000610.4 ENSP00000398632.2 P16070-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
167946
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.09e-7
AC:
1
AN:
1409450
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
696052
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32388
American (AMR)
AF:
0.00
AC:
0
AN:
36458
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25244
East Asian (EAS)
AF:
0.0000270
AC:
1
AN:
37006
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79982
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49754
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5678
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1084578
Other (OTH)
AF:
0.00
AC:
0
AN:
58362
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 12, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.40C>T (p.L14F) alteration is located in exon 1 (coding exon 1) of the CD44 gene. This alteration results from a C to T substitution at nucleotide position 40, causing the leucine (L) at amino acid position 14 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.057
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.67
.;D;T;.;T;.;.;.;.;.
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.077
N
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.27
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.8
L;L;.;L;.;L;.;L;L;L
PhyloP100
0.94
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.4
D;D;D;D;.;D;.;D;D;D
REVEL
Benign
0.032
Sift
Uncertain
0.0060
D;D;D;D;.;D;.;D;D;D
Sift4G
Uncertain
0.0060
D;D;D;D;D;D;.;D;D;D
Polyphen
0.079
B;D;.;D;.;P;.;.;B;.
Vest4
0.16
MutPred
0.49
Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);Loss of glycosylation at S18 (P = 0.1995);
MVP
0.53
MPC
0.82
ClinPred
0.91
D
GERP RS
-0.012
PromoterAI
0.041
Neutral
Varity_R
0.15
gMVP
0.77
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1489711013; hg19: chr11-35160890; API